Location History:
- Atlanta, GA (US) (2002 - 2006)
- Coconut Grove, FL (US) (2013)
Company Filing History:
Years Active: 2002-2013
Title: Innovations and Contributions of Charles B. Nemeroff
Introduction
Charles B. Nemeroff is a prominent inventor based in Atlanta, GA. He has made significant contributions to the field of pharmacology and neuroscience, particularly in the development of compounds and methods for treating neuropsychiatric disorders. With a total of 3 patents, his work has had a substantial impact on the understanding and treatment of conditions such as depression.
Latest Patents
Nemeroff's latest patents include innovative compounds, compositions, and methods of synthesis. One notable patent describes a series of triamino-pyridine derivatives and their labeled counterparts. These compounds are utilized in methods of imaging and treatment, particularly for conditions related to corticotropin releasing factor type-1 (CRF1). The disclosure also includes compositions that serve as ligands for the CRF1 receptor, which are essential for non-invasive imaging techniques such as positron emission tomography (PET) and SPECT imaging. Another significant patent outlines a method for assessing individual responses to antidepressant drug therapy by monitoring the transport inhibition of monoamine neurotransmitters in vitro.
Career Highlights
Charles B. Nemeroff is affiliated with Emory University, where he continues to advance research in neuropsychiatry. His work has been instrumental in developing new therapeutic approaches and understanding the underlying mechanisms of mental health disorders. His innovative research has garnered attention and respect within the scientific community.
Collaborations
Nemeroff has collaborated with notable colleagues, including Clinton D. Kilts and Jeff Stehouwer. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Charles B. Nemeroff's contributions to the field of pharmacology and neuroscience are noteworthy. His innovative patents and research efforts continue to shape the landscape of treatment for neuropsychiatric disorders. His work exemplifies the importance of innovation in improving mental health therapies.